Ads
related to: fda, breast cancer- Dosing Studies
View Dosing Regimen Schedules
And Safety Information
- What To Ask Your Doctor
Find Questions To Ask Your Doctor
To Help Get Started On Treatment
- Sign Up Here
Submit A Form to Learn More
About Financial Resources
- Support Program Resources
Get More Information About
HER2+ Patient Support Programs
- Downloads for Patients
Download Important Safety Info &
Guides for Patient on Treatment
- How Administration Works
Learn About How a Combination
Treatment Is Given to Patients
- Dosing Studies
Search results
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 6 days agoEGFR testing now needed for all patients with stage III disease, experts say
Rafferty Asset Management LLC Sells 52,956 Shares of Veracyte, Inc. (NASDAQ:VCYT)
ETF DAILY NEWS· 7 hours agoRafferty Asset Management LLC trimmed its stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 24.9% in the 4th quarter, according to its most recent disclosure with the Securities ...
Daily Briefing: Your condom in Congress
USA TODAY via Yahoo News· 3 days agoThe first MDMA-based PTSD treatment was rejected by the FDA. A pro rock climber was sentenced to life in prison for sexual assaults in ...New York hush...
...Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing...
The Parsons Sun· 2 days agoPICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medical meeting
Tempus Introduces New HER2 & FOLR1 Testing Solutions to Support Personalized Patient Care
Morningstar· 6 days agoTempus, a leader in artificial intelligence and precision medicine, announced new testing solutions to help physicians identify patients with HER2 or FOLR1 expressing tumors, which may make ...
...of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Puma...
Benzinga· 5 days agoPuma Biotechnology, Inc. PBYI, a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor ...
Lack of Insurance Keeps Many Americans From Best Cancer Meds
KPVI· 5 days agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. New policies are...
Bushwick biotech raises $7M seed round to advance genetic cancer therapy
Crain's New York Business· 5 days agoThe seed round, led by LifeSpan Vision Ventures with participation from quadraScope Ventures and other investors, will help Matter Bio move its early-stage injectable cancer
Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery
Tehachapi News· 5 days agoThe transformative approach to genomic sequencing yields the first validated high-sensitivity lung cancer screening test that could close gaps in screening. BALTIMORE and ...
Lack of insurance may prevent Americans from accessing best cancer drugs
UPI· 5 days agoAmong patients diagnosed with advanced melanomas, those who had private health insurance saw rates...